focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 191.00
Bid: 189.00
Ask: 193.00
Change: 0.00 (0.00%)
Spread: 4.00 (2.116%)
Open: 191.00
High: 0.00
Low: 0.00
Prev. Close: 191.00
VIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD)- Vipera / Sella Open Fintech Platform

28 Mar 2018 12:22

RNS Number : 2601J
Sella Open Fintech Platform Spa
28 March 2018
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Sella Open Fintech Platform S.p.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Banca Sella Holding S.p.A. (holding company of Sella Open Fintech Platform S.p.A.)

(c) Name of offeror in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sella Open Fintech Platform S.p.A.

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

22 March 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

40,000,000

12.5

nil

0

(2) Cash-settled derivatives:

 

nil

nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

nil

nil

 

TOTAL:

40,000,000

12.5

nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

nil

Details, including nature of the rights concerned and relevant percentages:

n/a

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 March 2018

Contact name:

David Floyd (EGR Broking Ltd) adviser to offeror

Telephone number:

01722 780639

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEPGUPGWUPRGGR
Date   Source Headline
29th Apr 20244:58 pmRNSTransaction in Own Shares
25th Apr 20245:01 pmRNSTransaction in Own Shares
24th Apr 20245:24 pmRNSTransaction in Own Shares - Replacement
24th Apr 20245:11 pmRNSTransaction in Own Shares
23rd Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 20244:56 pmRNSTransaction in Own Shares
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20245:13 pmRNSTransaction in Own Shares
4th Apr 20244:59 pmRNSTransaction in Own Shares
4th Apr 202411:39 amRNSStatement re MAR
2nd Apr 20247:00 amRNSAcquisitions and Year End Portfolio Valuation
19th Mar 20245:01 pmRNSTransaction in Own Shares
18th Mar 20244:49 pmRNSTransaction in Own Shares
14th Mar 20244:54 pmRNSTransaction in Own Shares
11th Mar 20245:06 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:49 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDividend Declaration
6th Feb 20245:01 pmRNSTransaction in Own Shares
22nd Dec 202312:26 pmRNSHolding(s) in Company
21st Dec 20234:30 pmRNSDirector/PDMR Shareholding
20th Dec 202311:09 amRNSDirector/PDMR Shareholding
15th Dec 20234:30 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20239:06 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSHalf-year Report
15th Nov 20237:00 amRNSChange of Auditor
27th Oct 20237:00 amRNSPortfolio Update
17th Oct 20237:00 amRNSAppointment of Corporate Broker
15th Sep 202310:46 amRNSHolding(s) in Company
13th Sep 20233:15 pmRNSTransaction in Own Shares
11th Sep 20234:57 pmRNSTransaction in Own Shares
8th Sep 202310:49 amRNSDividend Declaration
2nd Aug 20232:02 pmRNSResult of AGM
17th Jul 20234:58 pmRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
26th Jun 20236:28 pmRNSAnnual Financial Report
14th Apr 20237:00 amRNSAcquisition and Year End Portfolio Valuation
1st Mar 20237:00 amRNSTransaction in Own Shares
22nd Feb 202310:09 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20233:13 pmRNSDividend Declaration
3rd Feb 20237:00 amRNSTrading Statement
18th Nov 202210:36 amRNSDividend Declaration
18th Nov 202210:19 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.